PILOT
831175
XINGANJIANG
873167
Beijing Highlander Digital Technology
300065
4
Hangzhou Gaoxin Materials Technology
300478
5
Shijihengtong Technology
301428
US Stock MarketDetailed Quotes
JANX Janux Therapeutics
- 36.370
- -0.800-2.15%
Close Feb 14 16:00 ET
- 36.370
- 0.0000.00%
Post 20:01 ET
2.13BMarket Cap-31.09P/E (TTM)
38.075High35.900Low1.13MVolume37.510Open37.170Pre Close41.40MTurnover2.56%Turnover RatioLossP/E (Static)58.63MShares71.71052wk High3.25P/B1.61BFloat Cap8.95052wk Low--Dividend TTM44.22MShs Float71.710Historical High--Div YieldTTM5.85%Amplitude5.650Historical Low36.565Avg Price1Lot Size
Janux Therapeutics News
Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Meyer Andrew Hollman
Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Campbell David Alan
Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer McIver Zachariah
Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Winter Charles M.
Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Campbell David Alan
Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Robinson Byron
Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer DiRaimondo Thomas
Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Dobek Maria
Janux Therapeutics | 3/A: Initial statement of beneficial ownership of securities (Amendment)-Officer Winter Charles M.
Janux Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer McIver Zachariah
Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Meyer Andrew Hollman
Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Campbell David Alan
Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Meyer Andrew Hollman
Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Campbell David Alan
Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Campbell David Alan
Janux Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-David Campbell, Ph.D.(4.8%)
Janux Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Kenneth Griffin(2.0%),Citadel Advisors LLC(1.9%), etc.
Janux Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Biotechnology Value Fund, L.P.(0%),BVF I GP LLC(0%), etc.
Janux Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-FMR LLC(14.999%),Abigail P. Johnson(14.999%)
Janux Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Jay Lichter, Ph.D.(4.1%),Tighe Reardon(3.0%), etc.
Trending Stocks
Discussing
Major earnings are approaching! What's ahead for Chinese stocks in 2025?
Recently, institutions such as Goldman Sachs, Morgan Stanley, and Appaloosa LP have spoken positively about Chinese assets. 🎙️Discussion: 1
Popular on moomoo
Feb 13 17:34
China's asset revaluation sparks debate: What are mooers buying?